Review ArticleTopiramate: a review of preclinical, pharmacokinetic, and clinical data
References (35)
- et al.
Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy
Epilepsy Res
(1996) - et al.
Antiepileptic drugs: Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds
Pharmacol Rev
(1990) - et al.
Anticonvulsant O-alkyl sulfamates. 2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate and related compounds
J Med Chem
(1987) - et al.
Newer antiepileptic drugs: Towards an improved risk-benefit ratio
Drug Saf
(1994) - et al.
The novel anticonvulsant topiramate enhances GABA-mediated chloride flux
Epilepsia
(1993) - et al.
The investigational anticonvulsant topiramate potentiates GABA-evoked currents in mouse cortical neurons
Epilepsia
(1995) - et al.
Effects of topiramate on sustained repetitive firing and low Mg2+-induced seizure discharges in cultured hippocampal neurons
Epilepsia
(1995) - et al.
Topiramate selectively blocks kainate currents in cultured hippocampal neurons
Epilepsia
(1995) - et al.
Topiramate: Preclinical evaluation of a structurally novel anticonvulsant
Epilepsia
(1994) New antiepileptic drugs
Neurology
(1994)
Plasma pharmacokinetics in topiramate, a new anticonvulsant, in humans
Epilepsia
(1988)
Multiple-dose pharmacokinetics of topiramate in healthy male subjects
Epilepsia
(1988)
Comparative pharmacokinetics of the newer antiepileptic drugs
Clin Pharmacokinet
(1993)
The effect of food on the bioavailability of topiramate from 100-mg and 400-mg tablets in healthy male volunteers
Epilepsia
(1992)
The pharmacokinetics (PK) of topiramate (T) in subjects with renal impairment (RI) as compared to matched subjects with normal renal function (NRF)
Pharm Res
(1993)
The pharmacokinetics (PK) of topiramate (T) in subjects with end-stage renal disease undergoing hemodialysis
Clin Pharmacol Ther
(1994)
Cited by (0)
Copyright © 1997 Published by Elsevier Inc.